Clinical performance of hydrophilic, titanium‐zirconium dental implants in patients with well‐controlled and poorly controlled type 2 diabetes: One‐year results of a dual‐center cohort study
Authors:
- Jessica M. LatimerJLJessica M. Latimer
- Diane M. DaubertDDDiane M. Daubert
- ABCD study collaboratorsACABCD study collaborators
- Georgios A. KotsakisGKGeorgios A. Kotsakis
- 5 November 2021
- journal article
- research article
- Published by Wiley in Journal of Periodontology
- Vol. 93 (5) , 745-757
Abstract
Background: This study assessed the clinical performance of hydrophilic dental implants in a patient cohort with type 2 diabetes mellitus (T2DM).Methods: Subjects with T2DM of ≥2‐years duration were allocated to either the well‐controlled (WC; HbA1c ≤ 7.0%,) or poorly‐controlled (PC; 7.5 < HbA1c < 10%) groups in a dual‐center, prospective cohort study. Each subject received a single, titanium‐zirconium (Ti‐Zr) dental implant with a chemically‐modified, hydrophilic (modSLA) surface in a posterior mandibular site. Postoperatively, subjects were followed at 1, 2, 4, 8, and 12‐week intervals. Post‐loading, subjects were followed at 3, 6, and 12‐months. Clinical and radiographic parameters of implant success, and dental patient‐reported outcomes were collected.Results: Twenty‐one dental patients (NWC = 11; NPC = 10; mean age: 66.8 ± 7.5 years) were enrolled and the 1‐year implant success rate was 100%. Peri‐implant bone levels were stable with 0.15 ± 0.06 mm mean marginal loss at 1 year without significant inter‐group differences (P = 0.79). Postoperative pain was minimal at 1‐week, and OHIP‐5 scores decreased significantly over time as compared with preoperative levels (P < 0.001) suggesting significant improvement in patient‐perceived oral health following implant therapy.Conclusions: Elevated HbA1c levels > 7.5% did not compromise 1‐year success rates, or oral health‐related quality of life in PC patients receiving modSLA, Ti‐Zr implants. Given that implant placement up to 10% HbA1c significantly enhanced oral health‐related quality of life without complications or morbidity, the safety and efficacy of implants to improve oral function in T2DM is supported, even without ideal glycemic control.Keywords
This publication has 46 references indexed in Scilit:
- Hemoglobin A1C as a Marker for Surgical Risk in Diabetic Patients Undergoing Total Joint ArthroplastyThe Journal of Arthroplasty, 2013
- The Impact of Edentulism on Oral and General HealthInternational Journal of Dentistry, 2013
- A critical review of diabetes, glycemic control, and dental implant therapyClinical Oral Implants Research, 2011
- Osseointegration of SLActive implants in diabetic pigsClinical Oral Implants Research, 2011
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusDiabetes Care, 2011
- Type 1 Diabetes in Young Rats Leads to Progressive Trabecular Bone Loss, Cessation of Cortical Bone Growth, and Diminished Whole Bone Strength and Fatigue LifeJournal of Bone and Mineral Research, 2009
- Severe tooth loss in older adults as a key indicator of compromised dietary qualityPublic Health Nutrition, 2009
- Glycemic Control and Implant Stabilization in Type 2 Diabetes MellitusJournal of Dental Research, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003